EQRx’S Plan to Disrupt the Drug Market with CEO Melanie Nallicheri
By focusing on efficiency and leveraging technology, EQRx is aiming to “remake” medicine. CEO Melanie Nallicheri on her company’s plans to disrupt the drug industry by developing and delivering innovative new medicines at radically low prices.
April 28, 202213m 20s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
By focusing on efficiency and leveraging technology, EQRx is aiming to “remake” medicine. CEO Melanie Nallicheri on her company’s plans to disrupt the drug industry by developing and delivering innovative new medicines at radically low prices. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
Topics
drugsinnovative medicinespatientsinnovative treatmentsmedicines